The article by Faal et al. \[[@pmed-0030506-b001]\] describes differences in the level of *FOXP* *~3~* mRNA expression in the conjunctiva of patients with Chlamydia trachomatis infection. The authors suggest that their results may indicate a role for regulatory T cells in the resolution of conjunctival immune response, since *FOXP* *~3~* mRNA remained elevated even if clinical disease signs were present in the absence of infection.

But suggestions about the function of regulatory T cells in diseases based only on the quantification of *FOXP* *~3~* mRNA should be considered with great caution. According to the current state-of-the-art it is well established that *FOXP* *~3~* does not specify human regulatory T cells since it is expressed at the mRNA and the protein levels to different extents protein at \[[@pmed-0030506-b002]--[@pmed-0030506-b005]\]. Thus, without quantification of FOXP~3~ the single cell level in conjunction with reliable markers of human regulatory T cells, e.g., the recently identified lack of *CD127* expression on regulatory T cells \[[@pmed-0030506-b006],[@pmed-0030506-b007]\], the potential contribution or association of regulatory T cells with a disease cannot be assessed.
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